A gene variant has been identified by researchers that may be used to predict people most likely to respond to an investigational therapy under development for Alzheimer's disease (AD). The study, is based on experiments with cultured neurons derived from adult stem cells.
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario